Patient-Perceived Benefits of Named-Patient Product Sublingual Immunotherapy in Allergic Rhinitis and Asthma: Primary Results From the ERAPP Real-World Cohort Study

Allergic DiseasesImmunotherapy
Do you want to read an article? Please log in or register.